Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Short stature in advanced pediatric CKD is associated with faster time to reduced kidney function after transplant.

Li Y, Greenbaum LA, Warady BA, Furth SL, Ng DK.

Pediatr Nephrol. 2019 Jan 9. doi: 10.1007/s00467-018-4165-2. [Epub ahead of print]

PMID:
30627858
2.

Nephrotic Syndrome.

Wang CS, Greenbaum LA.

Pediatr Clin North Am. 2019 Feb;66(1):73-85. doi: 10.1016/j.pcl.2018.08.006. Review.

PMID:
30454752
3.

Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.

Selewski DT, Ambruzs JM, Appel GB, Bomback AS, Matar RB, Cai Y, Cattran DC, Chishti AS, D'Agati VD, D'Alessandri-Silva CJ, Gbadegesin RA, Hogan JJ, Iragorri S, Jennette JC, Julian BA, Khalid M, Lafayette RA, Liapis H, Lugani F, Mansfield SA, Mason S, Nachman PH, Nast CC, Nester CM, Noone DG, Novak J, O'Shaughnessy MM, Reich HN, Rheault MN, Rizk DV, Saha MK, Sanghani NS, Sperati CJ, Sreedharan R, Srivastava T, Swiatecka-Urban A, Twombley K, Vasylyeva TL, Weaver DJ, Yin H, Zee J, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Flessner M, Guay-Woodford LM, Kiryluk K; CureGN Consortium.

Kidney Int Rep. 2018 Aug 3;3(6):1373-1384. doi: 10.1016/j.ekir.2018.07.021. eCollection 2018 Nov.

4.

Correction to: Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings : A Midwest Pediatric Nephrology Consortium (MWPNC) study.

Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.

Pediatr Nephrol. 2019 Mar;34(3):539. doi: 10.1007/s00467-018-4103-3.

PMID:
30443740
5.

Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial.

Wang CS, Travers C, McCracken C, Leong T, Gbadegesin R, Quiroga A, Benfield MR, Hidalgo G, Srivastava T, Lo M, Yadin O, Mathias R, Araya CE, Khalid M, Orjuela A, Zaritsky J, Al-Akash S, Kamel M, Greenbaum LA.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1859-1865. doi: 10.2215/CJN.06890618. Epub 2018 Nov 15.

PMID:
30442868
6.

Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome.

Gasongo G, Greenbaum LA, Niel O, Kwon T, Macher MA, Maisin A, Baudouin V, Dossier C, Deschênes G, Hogan J.

Pediatr Nephrol. 2018 Nov 13. doi: 10.1007/s00467-018-4135-8. [Epub ahead of print]

PMID:
30426218
7.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM; CureGN Consortium.

Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9.

PMID:
30420158
8.

Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.

Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.

Pediatr Nephrol. 2018 Oct;33(10):1773-1780. doi: 10.1007/s00467-018-3994-3. Epub 2018 Jul 7. Erratum in: Pediatr Nephrol. 2019 Mar;34(3):539.

PMID:
29982878
9.

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, Lommelé Å, Kupelian V, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Licht C, Vande Walle J, Frémeaux-Bacchi V; Global aHUS Registry.

Kidney Int. 2018 Aug;94(2):408-418. doi: 10.1016/j.kint.2018.02.029. Epub 2018 Jun 19.

PMID:
29907460
10.

HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.

Adeyemo A, Esezobor C, Solarin A, Abeyagunawardena A, Kari JA, El Desoky S, Greenbaum LA, Kamel M, Kallash M, Silva C, Young A, Hunley TE, de Jesus-Gonzalez N, Srivastava T, Gbadegesin R.

Am J Kidney Dis. 2018 Mar;71(3):399-406. doi: 10.1053/j.ajkd.2017.10.013. Epub 2017 Dec 23.

PMID:
29277510
11.

Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.

Wang CS, Gander J, Patzer RE, Greenbaum LA.

Am J Kidney Dis. 2018 Mar;71(3):392-398. doi: 10.1053/j.ajkd.2017.09.025. Epub 2017 Dec 23.

PMID:
29277509
12.

Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.

Boneparth A, Radhakrishna SM, Greenbaum LA, Yen E, Okamura DM, Cooper JC, Mason S, Levy DM, Sule SD, Jensen PT, Yildirim-Toruner C, Ardoin SP, Wenderfer SE.

J Rheumatol. 2017 Nov;44(11):1619-1623. doi: 10.3899/jrheum.170502. Epub 2017 Sep 15.

PMID:
28916546
13.

Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs.

Varnell CD, Fukuda T, Kirby CL, Martin LJ, Warshaw BL, Patel HP, Chand DH, Barletta GM, Van Why SK, VanDeVoorde RG, Weaver DJ, Wilson A, Verghese PS, Vinks AA, Greenbaum LA, Goebel J, Hooper DK.

Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.13033. Epub 2017 Sep 4.

14.

Enhancing clinical trial development for pediatric kidney diseases.

Schnaper HW, Flynn JT, Gross C, Cropp AB, Dehmel B, Patel LB, Greenbaum LA, Houtsmuller E, Kaskel F, Moxey-Mims M, Nowak K, Silverstein D, Thompson A, Yao L, Darsey E, Smoyer WE.

Pediatr Res. 2017 Nov;82(5):727-732. doi: 10.1038/pr.2017.180. Epub 2017 Aug 30. Review.

15.

Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.

Selewski DT, Troost JP, Cummings D, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Carlozzi NE, Reeve BB, DeWalt DA, Gipson DS.

Health Qual Life Outcomes. 2017 Aug 23;15(1):166. doi: 10.1186/s12955-017-0737-2.

16.

Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report.

Akchurin OM, Kogon AJ, Kumar J, Sethna CB, Hammad HT, Christos PJ, Mahan JD, Greenbaum LA, Woroniecki R.

BMC Nephrol. 2017 May 30;18(1):181. doi: 10.1186/s12882-017-0599-1.

17.

Vascular Stiffness in Children With Chronic Kidney Disease.

Savant JD, Betoko A, Meyers KE, Mitsnefes M, Flynn JT, Townsend RR, Greenbaum LA, Dart A, Warady B, Furth SL.

Hypertension. 2017 May;69(5):863-869. doi: 10.1161/HYPERTENSIONAHA.116.07653. Epub 2017 Apr 3.

18.

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.

Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MB.

Pediatr Nephrol. 2017 Jul;32(7):1221-1232. doi: 10.1007/s00467-017-3579-6. Epub 2017 Mar 22.

19.

Childhood Nephrotic Syndrome Management and Outcome: A Single Center Retrospective Analysis.

Wang CS, Yan J, Palmer R, Bost J, Wolf MF, Greenbaum LA.

Int J Nephrol. 2017;2017:2029583. doi: 10.1155/2017/2029583. Epub 2017 Feb 23.

20.

Physical Activity and Kidney Injury in Pediatric and Young Adult Kidney Transplant Recipients.

Wolf MF, George RP, Warshaw B, Wang E, Greenbaum LA.

J Pediatr. 2016 Dec;179:90-95.e2. doi: 10.1016/j.jpeds.2016.08.079. Epub 2016 Oct 11.

PMID:
27742128
21.

Assessment of dietary intake of children with chronic kidney disease.

Hui WF, Betoko A, Savant JD, Abraham AG, Greenbaum LA, Warady B, Moxey-Mims MM, Furth SL.

Pediatr Nephrol. 2017 Mar;32(3):485-494. doi: 10.1007/s00467-016-3491-5. Epub 2016 Sep 29.

22.

Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.

Crespo-Salgado J, Vehaskari VM, Stewart T, Ferris M, Zhang Q, Wang G, Blanchard EE, Taylor CM, Kallash M, Greenbaum LA, Aviles DH.

Microbiome. 2016 Sep 17;4(1):50. doi: 10.1186/s40168-016-0195-9.

23.

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.

Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.

Kidney Int. 2016 Mar;89(3):701-11. doi: 10.1016/j.kint.2015.11.026. Epub 2016 Jan 28.

24.

Deep procedural sedation by a sedationist team for outpatient pediatric renal biopsies.

Kamat PP, Ayestaran FW, Gillespie SE, Sanders RD, Greenbaum LA, Simon HK, Stockwell JA.

Pediatr Transplant. 2016 May;20(3):372-7. doi: 10.1111/petr.12680. Epub 2016 Feb 12.

PMID:
26867508
25.

Perceived appetite and clinical outcomes in children with chronic kidney disease.

Ayestaran FW, Schneider MF, Kaskel FJ, Srivaths PR, Seo-Mayer PW, Moxey-Mims M, Furth SL, Warady BA, Greenbaum LA.

Pediatr Nephrol. 2016 Jul;31(7):1121-7. doi: 10.1007/s00467-016-3321-9. Epub 2016 Feb 8.

26.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

27.

The global aHUS registry: methodology and initial patient characteristics.

Licht C, Ardissino G, Ariceta G, Cohen D, Cole JA, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Schaefer F, Vande Walle J, Frémeaux-Bacchi V.

BMC Nephrol. 2015 Dec 10;16:207. doi: 10.1186/s12882-015-0195-1.

28.

Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, Nelson RD, Kiessling SG, Brophy PD, Quiroga A, Seifert ME, Straatmann CE, Mahan JD, Ferris ME, Troost JP, Gipson DS.

Pediatr Nephrol. 2016 Mar;31(3):465-72. doi: 10.1007/s00467-015-3236-x. Epub 2015 Oct 23.

29.

Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report.

Nadeem S, Hashmat S, Defreitas MJ, Westreich KD, Shatat IF, Selewski DT, Onder AM, Chiang M, Weaver DJ Jr, Steinke J, Barcia J, Hernandez J, Hidalgo G, Ingraham SE, Abitbol CL, Pan C, Greenbaum LA.

J Pediatr. 2015 Oct;167(4):881-5. doi: 10.1016/j.jpeds.2015.05.045. Epub 2015 Jun 27.

PMID:
26130112
30.

The US pediatric nephrology workforce: a report commissioned by the American Academy of Pediatrics.

Primack WA, Meyers KE, Kirkwood SJ, Ruch-Ross HS, Radabaugh CL, Greenbaum LA.

Am J Kidney Dis. 2015 Jul;66(1):33-9. doi: 10.1053/j.ajkd.2015.03.022. Epub 2015 Apr 22.

PMID:
25911315
31.

Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection.

Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.

Clin Pharmacol Ther. 2015 Jul;98(1):25-33. doi: 10.1002/cpt.127. Epub 2015 May 2.

32.

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.

Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S.

Am J Kidney Dis. 2015 Jun;65(6):878-88. doi: 10.1053/j.ajkd.2015.01.008. Epub 2015 Mar 19.

33.

The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

Selewski DT, Troost JP, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Song PX, Reeve BB, DeWalt DA, Gipson DS.

Pediatr Nephrol. 2015 Sep;30(9):1467-76. doi: 10.1007/s00467-015-3074-x. Epub 2015 Mar 18.

34.

Kidney transplantation in children with decreased left ventricular systolic function: a Midwest Pediatric Nephrology Consortium study.

Riar SK, Mitsnefes MM, Nehus EJ, Patel HP, Steinke JM, Crumb T, Abraham EC, Kamel MW, Greenbaum LA.

Pediatr Nephrol. 2015 Aug;30(8):1343-8. doi: 10.1007/s00467-015-3066-x. Epub 2015 Mar 8.

PMID:
25750075
35.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.

Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ, Delmas Y, Douglas K, Furman RR, Gaber OA, Goodship T, Herthelius M, Hourmant M, Legendre CM, Remuzzi G, Sheerin N, Trivelli A, Loirat C.

Kidney Int. 2015 May;87(5):1061-73. doi: 10.1038/ki.2014.423. Epub 2015 Feb 4.

36.

HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.

Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Janjua HS, Omoloja A, Barletta GM, Cai Y, Milford DD, O'Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP; Mid-West Pediatric Nephrology Consortium.

J Am Soc Nephrol. 2015 Jul;26(7):1701-10. doi: 10.1681/ASN.2014030247. Epub 2014 Oct 27.

37.

Fever of Unknown Origin (FUO) in a pediatric kidney transplant recipient: Questions and Answers.

Nadeem S, Sukumaran L, Siegel DA, Jernigan SM, Greenbaum LA.

Pediatr Nephrol. 2015 Dec;30(12):2109-13. doi: 10.1007/s00467-014-2974-5. Epub 2014 Oct 15. No abstract available.

PMID:
25315178
38.

Renal and urologic abnormalities in the perinatal period.

Rheault MN, Greenbaum LA.

Clin Perinatol. 2014 Sep;41(3):xix-xx. doi: 10.1016/j.clp.2014.06.001. Epub 2014 Jul 18. No abstract available.

PMID:
25155739
39.

Atypical hemolytic uremic syndrome.

Greenbaum LA.

Adv Pediatr. 2014 Aug;61(1):335-56. doi: 10.1016/j.yapd.2014.04.001. Epub 2014 May 17. Review. No abstract available.

PMID:
25037136
40.

Medication adherence and growth in children with CKD.

Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, Furth SL, Moxey-Mims M, Warady BA, Kaskel FJ, Skversky AL.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1519-25. doi: 10.2215/CJN.01150114. Epub 2014 Jun 26.

41.

Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate.

Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, Cornelissen EA, Morin D, Cochat P, Elenberg E, Hanna C, Gaillard S, Bagger MJ, Rioux P.

J Pediatr. 2014 Sep;165(3):528-33.e1. doi: 10.1016/j.jpeds.2014.05.013. Epub 2014 Jun 16.

42.

Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study.

Selewski DT, Massengill SF, Troost JP, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA, Gipson DS.

Pediatr Nephrol. 2014 Dec;29(12):2347-56. doi: 10.1007/s00467-014-2858-8. Epub 2014 Jun 9.

43.

Barriers, biases, and beliefs about arteriovenous fistula placement in children: a survey of the International Pediatric Fistula First Initiative (IPFFI) within the Midwest Pediatric Nephrology Consortium (MWPNC).

Chand DH, Geary D, Patel H, Greenbaum LA, Nailescu C, Brier ME, Valentini RP.

Hemodial Int. 2015 Jan;19(1):100-7. doi: 10.1111/hdi.12182. Epub 2014 May 28.

PMID:
24865851
44.

The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease.

Flynn JT, Ng DK, Chan GJ, Samuels J, Furth S, Warady B, Greenbaum LA; Chronic Kidney Disease in Children Study.

J Pediatr. 2014 Jul;165(1):154-162.e1. doi: 10.1016/j.jpeds.2014.02.051. Epub 2014 Mar 31.

45.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

46.

Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium.

Straatmann C, Ayoob R, Gbadegesin R, Gibson K, Rheault MN, Srivastava T, Tran CL, Gipson DS, Greenbaum LA, Smoyer WE, Vehaskari VM.

Pediatr Nephrol. 2013 Aug;28(8):1235-41. doi: 10.1007/s00467-013-2483-y. Epub 2013 Apr 30.

PMID:
23633037
47.

Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study.

Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA.

Health Qual Life Outcomes. 2013 Mar 4;11:30. doi: 10.1186/1477-7525-11-30.

48.

Restless legs syndrome in children with chronic kidney disease.

Riar SK, Leu RM, Turner-Green TC, Rye DB, Kendrick-Allwood SR, McCracken C, Bliwise DL, Greenbaum LA.

Pediatr Nephrol. 2013 May;28(5):773-95. doi: 10.1007/s00467-013-2408-9. Epub 2013 Jan 20.

PMID:
23334386
49.

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.

Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M.

Kidney Int. 2013 Apr;83(4):749-56. doi: 10.1038/ki.2012.428. Epub 2013 Jan 16.

50.

A new 'tac' for childhood nephrotic syndrome.

Becknell B, Greenbaum LA, Smoyer WE.

Kidney Int. 2012 Nov;82(10):1049-51. doi: 10.1038/ki.2012.272.

Supplemental Content

Loading ...
Support Center